PL1713503T3 - Hamowanie czynnika B, alternatywny szlak dopełniacza i związane z tym sposoby - Google Patents

Hamowanie czynnika B, alternatywny szlak dopełniacza i związane z tym sposoby

Info

Publication number
PL1713503T3
PL1713503T3 PL05722948T PL05722948T PL1713503T3 PL 1713503 T3 PL1713503 T3 PL 1713503T3 PL 05722948 T PL05722948 T PL 05722948T PL 05722948 T PL05722948 T PL 05722948T PL 1713503 T3 PL1713503 T3 PL 1713503T3
Authority
PL
Poland
Prior art keywords
inhibition
factor
complement pathway
methods related
alternative complement
Prior art date
Application number
PL05722948T
Other languages
English (en)
Inventor
Vernon Michael Holers
Joshua M Thurman
Christian Taube
Erwin W Gelfand
Gary Steven Gilkeson
Original Assignee
Univ Colorado Regents
Nat Jewish Health
Musc Found For Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2004/015040 external-priority patent/WO2004103288A2/en
Application filed by Univ Colorado Regents, Nat Jewish Health, Musc Found For Res Dev filed Critical Univ Colorado Regents
Publication of PL1713503T3 publication Critical patent/PL1713503T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
PL05722948T 2004-02-10 2005-02-10 Hamowanie czynnika B, alternatywny szlak dopełniacza i związane z tym sposoby PL1713503T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US54359404P 2004-02-10 2004-02-10
PCT/US2004/015040 WO2004103288A2 (en) 2003-05-13 2004-05-13 Method of preventing recurrent miscarriages
US63623904P 2004-12-14 2004-12-14
PCT/US2005/004346 WO2005077417A1 (en) 2004-02-10 2005-02-10 Inhibition of factor b, the alternative complement pathway and methods related thereto
EP05722948.6A EP1713503B1 (en) 2004-02-10 2005-02-10 Inhibition of factor b, the alternative complement pathway and methods related thereto

Publications (1)

Publication Number Publication Date
PL1713503T3 true PL1713503T3 (pl) 2014-02-28

Family

ID=34865159

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05722948T PL1713503T3 (pl) 2004-02-10 2005-02-10 Hamowanie czynnika B, alternatywny szlak dopełniacza i związane z tym sposoby

Country Status (5)

Country Link
EP (2) EP2340850A1 (pl)
AU (1) AU2005212369B2 (pl)
CA (1) CA2561531C (pl)
PL (1) PL1713503T3 (pl)
WO (1) WO2005077417A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1713503E (pt) 2004-02-10 2013-11-14 Nat Jewish Health Inibição do factor b, a via alternativa do complemento e métodos relacionados
CN101227924A (zh) * 2005-05-26 2008-07-23 科罗拉多大学评议会 用于治疗外伤性脑损伤、脊髓损伤及相关病症的补体旁路抑制
ES2523640T3 (es) 2006-06-21 2014-11-28 Musc Foundation For Research Development Direccionamiento del factor H del complemento para el tratamiento de enfermedades
EP2698166B1 (en) 2006-10-10 2015-09-30 Regenesance B.V. Complement inhibition for improved nerve regeneration
CA2680344A1 (en) 2007-03-14 2008-11-20 Woodruff Emlen Humaneered anti-factor b antibody
ME01699B (me) 2009-07-02 2014-09-20 Musc Found For Res Dev Metode za stimulaciju regeneracije jetre
AU2010314931A1 (en) 2009-11-05 2012-06-21 Taligen Therapeutics, Inc. Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis
BR112012029067A2 (pt) 2010-05-14 2019-09-24 Univ Colorado Regents grupos-alvo de receptor do complemento 2 (cr2) melhorados.
SG186397A1 (en) 2010-06-22 2013-01-30 Univ Colorado Regents Antibodies to the c3d fragment of complement component 3
PL2661433T3 (pl) 2011-01-04 2018-01-31 Novartis Ag Związki indolowe lub ich analogi użyteczne do leczenia zwyrodnienia plamki żółtej związanego z wiekiem (AMD)
WO2013177035A2 (en) 2012-05-24 2013-11-28 Alexion Pharmaceuticals, Inc. Humaneered anti-factor b antibody
WO2014002053A1 (en) 2012-06-28 2014-01-03 Novartis Ag Pyrrolidine derivatives and their use as complement pathway modulators
US9815819B2 (en) 2012-06-28 2017-11-14 Novartis Ag Complement pathway modulators and uses thereof
CN104379579B (zh) 2012-06-28 2017-03-08 诺华股份有限公司 吡咯烷衍生物及其作为补体途径调节剂的用途
ES2647124T3 (es) 2012-06-28 2017-12-19 Novartis Ag Derivados de pirrolidina y su uso como moduladores de la ruta del complemento
JP6214647B2 (ja) 2012-06-28 2017-10-18 ノバルティス アーゲー 補体経路モジュレーターおよびその使用
JP6238980B2 (ja) 2012-07-12 2017-11-29 ノバルティス アーゲー 補体経路モジュレーターおよびその使用
US10413620B2 (en) 2012-08-17 2019-09-17 The Regents Of The University Of Colorado, A Body Corporate Light-emitting versions of the monoclonal antibody to C3D (MAB 3D29) for imaging
AU2013302441B2 (en) 2012-08-17 2018-05-10 The Regents Of The University Of Colorado, A Body Corporate Compositions and methods for detecting complement activation
ES2514165B1 (es) * 2013-03-27 2015-09-09 Consejo Superior De Investigaciones Científicas (Csic) Anticuerpo anti-factor b, composición farmacéutica útil para el tratamiento de enfermedades del complemento y sus aplicaciones
PE20190626A1 (es) 2014-05-01 2019-04-26 Ionis Pharmaceuticals Inc Composiciones y metodos para modular la expresion del factor b del complemento
MX2018012176A (es) 2016-04-04 2019-02-07 Bioverativ Usa Inc Anticuerpos anti-factor bb del complemento y usos de estos.
CN111527105A (zh) * 2017-10-11 2020-08-11 美国比奥维拉迪维股份有限公司 诱导补体活性的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
CA2043472A1 (en) 1990-06-04 1991-12-05 Mitsutaka Miyabayashi Electrode for secondary battery
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0542810A1 (en) 1990-08-02 1993-05-26 B.R. Centre Limited Methods for the production of proteins with a desired function
GB9109645D0 (en) 1991-05-03 1991-06-26 Celltech Ltd Recombinant antibodies
US5858657A (en) 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
DE69230142T2 (de) 1991-05-15 2000-03-09 Cambridge Antibody Tech Verfahren zur herstellung von spezifischen bindungspaargliedern
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US6165463A (en) 1997-10-16 2000-12-26 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
US5705151A (en) 1995-05-18 1998-01-06 National Jewish Center For Immunology & Respiratory Medicine Gene therapy for T cell regulation
AU1705100A (en) * 1998-10-09 2000-05-01 Musc Foundation For Research Development Blocking factor b to treat complement-mediated immune disease
GB9930659D0 (en) 1999-12-24 2000-02-16 Bio Discovery Ltd Inhibitors of complement activation
US6820011B2 (en) 2001-04-11 2004-11-16 The Regents Of The University Of Colorado Three-dimensional structure of complement receptor type 2 and uses thereof
US20040015040A1 (en) 2002-07-18 2004-01-22 The University Of Cincinnati Flexible, torsionable cardiac framework for heart wall actuation of the natural heart
AU2003270330B2 (en) 2002-09-06 2009-07-30 Alexion Pharmaceuticals, Inc. Method of treatment of asthma using antibodies to complement component C5
US20070123466A1 (en) * 2003-05-13 2007-05-31 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method of treating recurrent miscarriages

Also Published As

Publication number Publication date
EP1713503A4 (en) 2008-08-06
EP1713503A1 (en) 2006-10-25
EP1713503B1 (en) 2013-07-31
AU2005212369B2 (en) 2011-06-23
EP2340850A9 (en) 2012-02-29
EP2340850A1 (en) 2011-07-06
AU2005212369A1 (en) 2005-08-25
WO2005077417A1 (en) 2005-08-25
CA2561531C (en) 2017-05-02
CA2561531A1 (en) 2005-08-25

Similar Documents

Publication Publication Date Title
EP1713503A4 (en) INHIBITION OF FACTOR B AND ALTERNATIVE COMPLEMENT PATHWAY AND ASSOCIATED METHODS
MX286273B (es) Composiciones y metodos para inhibicion de la via jak.
HK1209729A1 (en) Compounds, compositions and methods
SG156674A1 (en) Asphaltene inhibition
DK1713503T3 (da) Hæmning af faktor b, den alternative komplemenpathway og dertil relaterede fremgangsmåde
EP1796489A4 (en) PROTECTIVE SHOES AND METHOD FOR PRODUCING THE SAME
HK1101911A1 (en) Tetrahydrocarbozoles and derivatives
EP1824467A4 (en) APOGOSSYPOLON AND ITS USES
IL178888A0 (en) Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
EP1789055A4 (en) INHIBITORS OF THIAZOLOPYRIDINE KINASE
SI1713503T1 (sl) Inhibicija faktorja B, alternativna komplementa pot in relevantni postopki
IL177759A0 (en) Cospeptin, cosmedin and their uses
GB0514024D0 (en) Padlock
GB2418628B (en) Improved laminates and the manufacture thereof
GB0414760D0 (en) The alternative
GB0400537D0 (en) Le beanock/the beanock
GB0428239D0 (en) Padlock
GB2420465B (en) The smelly-vision
GB2414745B (en) Euroblock - flood prevention specification
GB0419656D0 (en) The bugcap
EP1827454A4 (en) KINASE-HASPIN BASED COMPOSITIONS AND METHODS
GB0405592D0 (en) The degravitator
GB0417973D0 (en) The cat-stand
GB0416747D0 (en) The malarkey
GB0426869D0 (en) The sofawash